| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 04/15/2003 | US6548567 Ionic compounds with delocalized anionic charge, and their use as ion conducting components or as catalysts |
| 04/15/2003 | US6548557 Neutralization of phosphate esters, compositions based upon and methods using same |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548042 Bis-phosphonate compounds |
| 04/10/2003 | WO2003030151A2 Lubricant for magnetic recording medium and use thereof |
| 04/10/2003 | WO2003029260A1 Process for synthesis of organometallic compounds |
| 04/10/2003 | WO2003029259A1 Novel disphospines, their complexes with transition metals and their use in asymmetric synthesis |
| 04/10/2003 | WO2003029258A1 Oligomeric, hydroxy-terminated phosphonates |
| 04/10/2003 | WO2003029257A1 (ethylene)-(propene/butene)-phosphodiester triamine pentaacetic acid derivatives |
| 04/10/2003 | WO2003029137A2 Derivatization and solubilization of insoluble classes of fullerenes |
| 04/10/2003 | WO2003028713A2 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 04/10/2003 | WO2003028629A2 Chlorin photosensitizing agents for use in photodynamic therapy |
| 04/10/2003 | WO2003028628A2 Photosensitizing carbamate derivatives |
| 04/10/2003 | WO2003002974A3 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 04/10/2003 | WO2003000186A3 Novel phenylamino-pyrimidines and uses thereof |
| 04/10/2003 | WO2002102793A3 Quinazolinediones as antibacterial agents |
| 04/10/2003 | WO2002036557B1 Fluoroborate salts comprising a reactive cation and uses thereof |
| 04/10/2003 | US20030069448 Organic luminescent material for flat panel displays, emits intense yellow or red light; efficient production |
| 04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/10/2003 | US20030069412 Synthesis of oligonucleotides |
| 04/10/2003 | US20030069212 Synthesis of A-ring synthon of 19-nor-1alpha, 25-dihydroxyvitamin D3 from (D)-glucose |
| 04/10/2003 | US20030069209 Menthol derivatives and process for preparing the same |
| 04/10/2003 | US20030069208 Lipophilic cation, preferably triphenylphosphonium, covalently coupled to an antioxidant moiety that is capable of being transported through the mitochondrial membrane and accumulated within the mitochondria of intact cells |
| 04/10/2003 | US20030069192 May be administered along with Rutin, a Rutin congener and/or a Rutin derivative. |
| 04/10/2003 | US20030068633 Preparation of expression vector; prepare microarray on substrate, incubate with pool of single stranded nucleotide sequences, detect bound sequences, release sequences from microarray, allow sequences to aggregate, recover sequences |
| 04/10/2003 | US20030066988 Electroconductivity coloring |
| 04/10/2003 | CA2462508A1 Photosensitizing carbamate derivatives |
| 04/10/2003 | CA2462261A1 Chlorin photosensitizing agents for use in photodynamic therapy |
| 04/10/2003 | CA2461191A1 A method for synthesizing an organometallic compound |
| 04/09/2003 | EP1300409A1 Phosphorus-containing hydroquinone derivatives, process for their production, phosphorus-containing epoxy resins made by using the derivatives, flame-retardant resin compositions, sealing media and laminated sheets |
| 04/09/2003 | EP1299401A1 Chiral ligands for asymmetric catalysis |
| 04/09/2003 | EP1299400A1 Novel cytotoxic compounds and their use |
| 04/09/2003 | EP1299342A1 Method for producing 3,3-diarylpropylamines |
| 04/09/2003 | EP1299337A1 Hydroxyphenstatin and the prodrugs thereof |
| 04/09/2003 | EP1153929B1 Process for producing phosphorohalidates |
| 04/09/2003 | EP1121337B1 Preparation of cyclopropylethyne and intermediates for preparation of cyclopropylethyne |
| 04/09/2003 | EP1080096B1 Novel furylphosphines and organometallic complexes containing them |
| 04/09/2003 | EP1042270B1 Asymmetric hydrogenation |
| 04/09/2003 | EP1023301B1 A heterocyclic chemical compound |
| 04/09/2003 | EP1007519B1 Compounds for use in the treatment of cancer |
| 04/09/2003 | EP1003758B1 Solution phase synthesis of oligonucleotides |
| 04/09/2003 | EP1000020B1 Hydrocyanation of diolefins and isomerization of nonconjugated 2-alkyl-3-monoalkenenitriles |
| 04/09/2003 | EP0796265B1 Process for making hydroxy-terminated aromatic oligomeric phosphates |
| 04/09/2003 | EP0555400B1 Polyacrylic acid compositions for textile processing |
| 04/09/2003 | CN1409716A New amino propylphosphinic acid |
| 04/09/2003 | CN1409709A Substituted bisindolylmaleimides for inhibition of cell proliferation |
| 04/09/2003 | CN1408716A Process for preparing powdered soy bean phosphatide |
| 04/09/2003 | CN1105118C Method for producing high melting-point polyolefines |
| 04/09/2003 | CN1105117C Pharmaceutical aminophosphonic acid drivatives |
| 04/08/2003 | USRE38073 Biosynthesis; using dehydration agent |
| 04/08/2003 | US6545183 Process for preparing cyclic phosphines |
| 04/08/2003 | US6545169 Anticancer, antiprotozoa agents |
| 04/08/2003 | US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/08/2003 | US6544919 Multinuclear transition metal catalysts for preparation of multimodal polymer compositions |
| 04/08/2003 | US6544499 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care |
| 04/08/2003 | US6544442 Complex of tributyl phosphate and metal; scintillators |
| 04/03/2003 | WO2003027314A2 Protected linker compounds |
| 04/03/2003 | WO2003027208A1 Phosphorus-containing carboxylic acid derivatives, process for preparation thereof, and flame retardants |
| 04/03/2003 | WO2003027129A1 Beta-ketophosphonates |
| 04/03/2003 | WO2003027128A1 Chemical compounds |
| 04/03/2003 | WO2003027058A1 Sphingolipids |
| 04/03/2003 | WO2002102766A3 Combretastatin a-3 prodrug |
| 04/03/2003 | WO2002072661A1 Polymer containing 9-oxo-9-phosphafluorene-2,7-diyl skeleton in backbone and process for producing the same |
| 04/03/2003 | WO2002006279A9 Efficient method of synthesizing combretastatin a-4 prodrugs |
| 04/03/2003 | US20030065214 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
| 04/03/2003 | US20030065208 Triphenylphosphine derivative, production process therefor, palladium complex thereof, and process for producing biaryl derivative |
| 04/03/2003 | US20030065206 High molecular weight; cyclopropanation in aprotic solvent |
| 04/03/2003 | US20030065205 Using mixture of inert gas and steam |
| 04/03/2003 | US20030065203 Using coordination polymerization catalysts |
| 04/03/2003 | US20030065195 Ether compounds |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065181 Novel chiral phosphorus ligands and the use thereof in the production of optically active products |
| 04/03/2003 | US20030065177 High boiling inhibitors for distillable, polymerizable monomers |
| 04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
| 04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
| 04/03/2003 | US20030064997 Novel compounds |
| 04/03/2003 | US20030064984 Anticancer agents; side effect reduction |
| 04/03/2003 | US20030064980 Respiratory system disorders; antiinflammatory agents |
| 04/03/2003 | US20030064893 Applying to a plant or seed a composition comprising lysophospholipid, e.g., lysophosphatidylethanolamine, lysophosphatidylinositol; protection aganist chilling, freezing, wind, drought, heat, chemicals or imbibation |
| 04/03/2003 | CA2461801A1 Sphingolipids |
| 04/02/2003 | EP1298136A2 Chiral monophosphorus compounds |
| 04/02/2003 | EP1296997A1 Base analogues |
| 04/02/2003 | EP1296994A1 Ferrocenyl diphosphines and their use |
| 04/02/2003 | EP1296993A1 Metallic compounds and the use thereof in the polymerisation of olefins |
| 04/02/2003 | EP1296992A2 Phosphacyclohexanes and the use thereof in the hydroformylation of olefins |
| 04/02/2003 | EP1296932A1 Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryots, fungi, protozoa or algae |
| 04/02/2003 | EP1296678A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 04/02/2003 | EP1296634A1 Dental material containing phosphonic acids |
| 04/02/2003 | EP1261612A4 Crystalline forms of antibiotic side chain intermediates |
| 04/02/2003 | EP1198466B1 Method of producing glyphosate or a salt thereof |
| 04/02/2003 | EP1112278B1 Catalyst component having at least a phosphinimine ligand and a heteroatom ligand |
| 04/02/2003 | EP1068214B1 Lewis base adducts of anhydrous mononuclear tris(beta-diketonate) bismuth compositions for deposition of bismuth-containing films, and method of making the same |
| 04/02/2003 | EP1021452B1 Process for synthesizing phosphodiesters |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0819119B1 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| 04/02/2003 | EP0717639B1 Polyamino paramagnetic chelates which contain both phosphonate and non-phosphonate moieties for mri |
| 04/02/2003 | CN1407986A Novel imidazotriazinones and the use thereof |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |